title: [Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report].
authors.affiliation: Service de Médecine Interne, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Université Paris-Nord, UPRES EA 3409, 125, rue de Stalingrad, 93000 Bobigny, France.
authors.forename: Marita
authors.initials: M
authors.lastname: Andreu
authors.forename: Jacky
authors.initials: J
authors.lastname: Ramanoelina
authors.forename: Franck
authors.initials: F
authors.lastname: Fajnkuchen
authors.forename: Luc
authors.initials: L
authors.lastname: Mouthon
authors.forename: Pascal
authors.initials: P
authors.lastname: Cohen
authors.forename: Liliane
authors.initials: L
authors.lastname: Laroche
authors.forename: Loïc
authors.initials: L
authors.lastname: Guillevin
mesh_terms: D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab